These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26865319)

  • 21. Management of drug and food interactions with azole antifungal agents in transplant recipients.
    Dodds-Ashley E
    Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?
    Hof H
    Drug Resist Updat; 2008; 11(1-2):25-31. PubMed ID: 18325827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology.
    des Champs-Bro B; Leroy-Cotteau A; Mazingue F; Pasquier F; François N; Corm S; Lemaitre L; Poulain D; Yakoub-Agha I; Alfandari S; Sendid B
    J Clin Pharm Ther; 2011 Apr; 36(2):152-60. PubMed ID: 21366643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Systemic antifungal drugs].
    Quiles-Melero I; García-Rodríguez J
    Rev Iberoam Micol; 2021; 38(2):42-46. PubMed ID: 34294519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal treatment in pediatric patients.
    Zaoutis TE; Benjamin DK; Steinbach WJ
    Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to manage antifungal drug resistance.
    Tseng HK; Perfect JR
    Expert Opin Pharmacother; 2011 Feb; 12(2):241-56. PubMed ID: 21226635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal drug resistance of pathogenic fungi.
    Kontoyiannis DP; Lewis RE
    Lancet; 2002 Mar; 359(9312):1135-44. PubMed ID: 11943280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Worldwide emergence of resistance to antifungal drugs challenges human health and food security.
    Fisher MC; Hawkins NJ; Sanglard D; Gurr SJ
    Science; 2018 May; 360(6390):739-742. PubMed ID: 29773744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.
    Singh N
    Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009.
    Zarb P; Amadeo B; Muller A; Drapier N; Vankerckhoven V; Davey P; Goossens H;
    Clin Microbiol Infect; 2012 Oct; 18(10):E389-95. PubMed ID: 22827696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azole antifungals: 35 years of invasive fungal infection management.
    Allen D; Wilson D; Drew R; Perfect J
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):787-98. PubMed ID: 25843556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.
    Kanafani ZA; Perfect JR
    Clin Infect Dis; 2008 Jan; 46(1):120-8. PubMed ID: 18171227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of pharmacokinetic considerations for selecting therapy in the treatment of invasive fungal infections.
    Lewis RE
    Am J Ther; 2012 Jan; 19(1):51-63. PubMed ID: 21248618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic antifungal drug use in Belgium-One of the biggest antifungal consumers in Europe.
    Goemaere B; Lagrou K; Spriet I; Hendrickx M; Vandael E; Becker P; Catry B
    Mycoses; 2019 Jun; 62(6):542-550. PubMed ID: 30887582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal drug resistance: evolution, mechanisms and impact.
    Revie NM; Iyer KR; Robbins N; Cowen LE
    Curr Opin Microbiol; 2018 Oct; 45():70-76. PubMed ID: 29547801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance.
    Albataineh MT; Sutton DA; Fothergill AW; Wiederhold NP
    Infect Dis Clin North Am; 2016 Mar; 30(1):13-35. PubMed ID: 26739605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of treatment options for invasive fungal infections.
    Pound MW; Townsend ML; Dimondi V; Wilson D; Drew RH
    Med Mycol; 2011 Aug; 49(6):561-80. PubMed ID: 21366509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of invasive fungal infections: a role for polyenes.
    Chandrasekar P
    J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.